Race specific hypermethylation has been reported in a prostate cancer study where black men show a higher percentage of methylation on the CD44 promoter-region, compared to white men [51,52]; black men are almost twice as likely to exhibit CD44 hypermethylation compared to white men independent of tumor grade or disease stage [53]. This evidence concerns the gene CD44 and prostate cancer.